In this interview, Prof. Dominique Brémond-Gignac (France), together with HOYA Vision Care, discusses the first cost-estimation study on active myopia management in Europe, conducted in France and the UK.
The findings reveal that early intervention with defocus spectacle lenses (DIMS/MDP Technology) is both clinically effective and cost-saving, particularly for fast-progressing children. Over time, active management can reduce lifetime myopia-related costs by approximately $13,000 in France and $24,000 in the UK.
Prof. Brémond-Gignac highlights how fixed reimbursement rates and growing clinician awareness are helping make myopia control more accessible, emphasizing that early, standardized intervention benefits both children’s vision and healthcare systems.
Learn more at HOYA Vision Care’s website: https://www.hoyavision.com/
This content is intended exclusively for healthcare professionals and eye care practitioners. It is not intended for the general public. Products or therapies discussed may not be registered or approved in all jurisdictions, including Singapore.
